| 臺大學術典藏 |
2018-09-10T08:28:52Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu, J.-Y. and Shih, J.-Y. and Chen, K.-Y. and Yang, C.-H. and Yu, C.-J. and Yang, P.-C.; Chong-Jen Yu; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-05-26T09:27:12Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y;Shih J.-Y;Chen K.-Y;Chih-Hsin Yang;Yu C.-J;Yang P.-C.; Wu J.-Y; Shih J.-Y; Chen K.-Y; CHIH-HSIN YANG; Yu C.-J; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:23Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Yang P.-C.; Wu J.-Y.;Shih J.-Y.;Chen K.-Y.;Yang C.-H.;Chong-Jen Yu;Yang P.-C.; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-13T06:33:53Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Wu J.-Y.;Jin-Yuan Shih;Chen K.-Y.;Yang C.-H.;Yu C.-J.;Yang P.-C.; Yang P.-C.; JIN-YUAN SHIH; Chen K.-Y.; Yang C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-12-02T02:34:10Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; Pan-Chyr Yang; Wu J.-Y.; Shih J.-Y.; Chen K.-Y.; Yang C.-H.; Yu C.-J.; PAN-CHYR YANG |
| 臺大學術典藏 |
2021-04-29T02:38:41Z |
Gefitinib therapy in patients with advanced non-small cell lung cancer with or without testing for epidermal growth factor receptor (EGFR) mutations
|
Anonymous |
| 臺大學術典藏 |
2022-08-19T00:21:13Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Shih J.-Y.; CHIUN HSU; Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2018-09-10T05:11:38Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su, W.-P. and Yang, C.-H. and Yu, C.-J. and Shih, J.-Y. and Hsu, C. and Yang, P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-04-10T12:51:27Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.;Yang C.-H.;Yu C.-J.;Shih J.-Y.;Chiun Hsu;Yang P.-C.; Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Chiun Hsu; Yang P.-C. |
| 臺大學術典藏 |
2020-05-26T09:27:27Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P;Chih-Hsin Yang;Yu C.-J;Shih J.-Y;Hsu C;Yang P.-C.; Su W.-P; CHIH-HSIN YANG; Yu C.-J; Shih J.-Y; Hsu C; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:34:06Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.; Yang C.-H.; Yu C.-J.; JIN-YUAN SHIH; Hsu C.; Yang P.-C.; Su W.-P.;Yang C.-H.;Yu C.-J.;Jin-Yuan Shih;Hsu C.;Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:50Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.;Yang C.-H.;Chong-Jen Yu;Shih J.-Y.;Hsu C.;Yang P.-C.; Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:35:37Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.;Yang C.-H.;Yu C.-J.;Shih J.-Y.;Hsu C.;Pan-Chyr Yang; Su W.-P.; Yang C.-H.; Yu C.-J.; Shih J.-Y.; Hsu C.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:06:37Z |
Gefitinib treatment for non-small cell lung cancer - A study including patients with poor performance status
|
Su W.-P.; Yang C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu C.; Yang P.-C. |
| 國立臺灣大學 |
2005 |
Gefitinib Treatment for Non-Small Cell Lung Cancer-a Study Including Patients with Poor Performance Status
|
蘇文彬; 楊志新; 余忠仁; 楊泮池; 施金元; 許駿; 楊志新; SU, WEN-PIN; YANG, CHIH-HSIN; YU, CHONG-JEN; YANG, PAN-CHYR; SHIH, JIN-YUAN; HSU, CHIUN |
| 國立臺灣大學 |
2011 |
Gefitinib-Induced Epidermal Growth Factor Receptor-Independent Keratinocyte Apoptosis Is Mediated by the Jnk Activation Pathway
|
呂柏萱; 朱家瑜; LU, PO-HSUAN; CHU, CHIA-YU |
| 臺大學術典藏 |
2019-12-04T08:43:54Z |
Gefitinib-induced epidermal growth factor receptor-independent keratinocyte apoptosis is mediated by the JNK activation pathway
|
Kuo T.-C.; Chang K.-C.; Chang C.-H.; CHIA-YU CHU; Lu P.-H.; Lu P.-H. ;Kuo T.-C. ;Chang K.-C. ;Chang C.-H. ;Chia-Yu Chu |
| 國立臺灣大學 |
2013 |
Gefitinib-Related Interstitial Lung Disease in Taiwanese Patients With Non-Small-Cell Lung Cancer
|
Chang, Shih-Chieh; Chang, Cheng-Yu; Chang, Shu-Ju; Yuan, Mei-Kang; Lai, Yi-Chun; Liu, Yu-Chang; Chen, Cheng-Yu; Kuo, Li-Chiao; Yu, Chong-Jen; 余忠仁 |
| 臺大學術典藏 |
2022-06-27T07:02:03Z |
Gefitinib-related interstitial lung disease in Taiwanese patients with non-small-cell lung cancer
|
Chang S.-C.; Chang C.-Y.; Chang S.-J.; Yuan M.-K.; Lai Y.-C.; Liu Y.-C.; Chen C.-Y.; Kuo L.-C.; CHONG-JEN YU |
| 國立交通大學 |
2014-12-12T01:31:13Z |
Gefitinib誘發細胞凋亡經由表皮生長因子接受器非依賴性路徑的分子機制
|
余勝壹; Yu, Sheng-Yi; 趙瑞益; Chao, Jui-I |
| 國立臺灣大學 |
2005 |
Gegen den Strom schwimmen. Die fr?he Prosa Adalbert Stifters als Vorl?uferin eines kombinierten k?nstlerisch-naturwissenschaftlichen Schreibens, dargestellt an seinem Erstwerk, "Der Condor"
|
Suitbert Oberreiter |
| 國立高雄大學 |
2006-07-06 |
Gegenwart und Vergangenheit des taiwanesischen Strafprozessrechts
|
吳俊毅 |
| 淡江大學 |
2009 |
GeH4以不同入射角度在Ge(100)表面上解離吸附的理論研究
|
葛玉環; Ger, Yuh-hwan |
| 南華大學 |
2000 |
GEICO Caveman: A Contemporary Tale of Mediated Otherness and Political Correctness
|
余季音;Yu, Chi-Ying |
| 高雄醫學大學 |
1998 |
Geiparvarin Analogues: Synthesis and Anticancer Evaluation of a-Mehtylene-g-butyrolactone Bearing Coumarins
|
陳義龍;王泰吉;曾誠齊 |
